NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect
暂无分享,去创建一个
Takayoshi Suzuki | K. Tozawa | A. Naiki‐Ito | Satoru Takahashi | T. Naiki | T. Etani | R. Ando | N. Kawai | K. Kohri | N. Miyata | K. Iida